Kynurenine 3-hydroxylase inhibitors for the treatment of diabetes
US7727977B2 · kind B2 · utility
2Cited by
5References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 18, 2003 |
| Grant date | Jun 1, 2010 |
| Priority date | — |
| Expiry date | Apr 3, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of at least one compound with inhibitory activity on kynurenine 3-hydroxylase for the preparation of a medicament for the prevention and/or treatment of diabetes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.